Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/1984
02/28/1984CA1162857A1 Solubilization of ivermectin in water
02/28/1984CA1162781A1 Growth promotant controlled release formulations and method of treatment
02/22/1984EP0101418A2 Pharmaceutical mixture
02/22/1984EP0101294A2 Composition for protecting and healing gastro-duodenal mucosa and the liver of mammals
02/22/1984EP0101178A2 Topical anti-inflammatory compositions
02/22/1984EP0101027A1 Organic compounds bonded to SiO2, process for preparing them and their use
02/21/1984US4433076 Coating agent for medicaments and methods for making and using the same
02/21/1984US4432802 Inclusion compound-containing composite
02/21/1984CA1162479A1 Pharmaceutical formulations containing cisplatin
02/15/1984EP0100592A1 Eye ointments and a method for their production
02/15/1984EP0100424A2 Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
02/14/1984US4431837 Long chain aliphatic hydrocarbon ethoxylated alcohol benzoates
02/14/1984US4431833 Prostaglandin and hydroxylated fatty acid ester formulations
02/14/1984US4431631 Aqueous oral solution
02/07/1984US4430340 Stabilization of PGI2 compounds with surfactants
02/07/1984US4430250 Hydrophilic polyepichlorohydrins; cosmetics; drug excipients; nonsensitivity
02/02/1984WO1984000299A1 Polypeptide-toxin hybrid protein
02/02/1984WO1984000294A1 A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
01/1984
01/31/1984US4429097 Drilling fluids, waterbase paints, textile printing pastes
01/31/1984US4428965 Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the Anacardiaceae and Ginkgoaceae families
01/31/1984US4428951 Tiaramide in water-insoluble oil or wax
01/31/1984US4428885 Esterification reaction products
01/25/1984EP0099133A2 Anti-cancer drugs comprising platinum complexes
01/24/1984US4427681 Microcrystalline cellulose gel, sodium carboxymethyl cellulose, titanium dioxide
01/24/1984US4427670 Containing corticosteroid, phosphatide, and butylhydroxyanisole, or butylhydroxytoluene
01/24/1984US4427648 Intimate mixture with acid or acid salt for increased bioavailability, cardiovascular disorders
01/24/1984CA1161193A1 Method for the production of iodophor powders
01/24/1984CA1160958A1 Cosmetic toner formulation
01/24/1984CA1160957A1 Cosmetic cream formulation
01/24/1984CA1160955A1 Cosmetic cleanser formulation
01/19/1984WO1984000111A1 Pharmaceutical gel composition
01/18/1984EP0098814A1 Antithrombin-heparin complex
01/18/1984EP0098568A2 Corticoids-containing preparation for topical application
01/17/1984CA1160572A1 Oxidation-stable solution containing at least one essential fatty acid and jujube oil, and cosmetic compositions made therefrom
01/17/1984CA1160571A1 Antitumor compositions
01/11/1984EP0098110A2 Long-acting composition
01/11/1984EP0098073A2 Powdery pharmaceutical composition of myeloperoxidase
01/10/1984US4425364 Compositions containing an organo-silicon compound
01/10/1984US4425337 A phenothiazine for absorption
01/10/1984US4425336 3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes
01/10/1984CA1160159A1 Cosmetic or pharmaceutical compounds in the form of stable oil in water emulsions
01/04/1984EP0097518A2 Monoclonal antibody
01/04/1984EP0097481A1 Emulsion containing prostaglandin E1 and method for production thereof
01/04/1984EP0097374A2 Corticosteroid topical preparation
01/04/1984EP0097373A2 Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same
01/03/1984US4424348 Methods of manufacture of nitrile-containing glucuronic acid conjugates
01/03/1984US4424210 Vehicle composition containing 1-substituted azacycloalkan-2-ones
01/03/1984US4424209 3,4-Di-isobutyryloxy-N- 3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl!-beta-phenethylamine cyclodextrin complexes
01/03/1984CA1159767A1 Ubidecarenone composition enhancing the absorption
01/03/1984CA1159766A1 Phthalazinol preparation
12/1983
12/28/1983EP0096981A2 Coloured intagliated articles
12/28/1983EP0096942A2 Oxytetracycline composition and process for preparing an oxytetracycline composition
12/28/1983EP0096933A2 Process for making a lyophilized product for use in skeletal imaging
12/28/1983EP0096930A2 Stable radiographic imaging agents
12/27/1983US4423199 Acrylamide containing emulsion copolymers for thickening purposes
12/27/1983US4423099 Two polymers of differing permeability
12/27/1983US4423043 Aqueous liquid formulations for control of bacterial and protozoal diseases
12/27/1983US4423040 Vehicle composition containing 1-substituted azacyclohexan-2-ones
12/27/1983US4423033 Pharmaceutical compositions
12/27/1983US4422952 Emulsions of the water-in-oil type useable as cosmetic supports or pharmaceutical excipients
12/27/1983US4422880 Precipitated siliceous products
12/27/1983CA1159367A1 Parenteral solvent and a process for the preparation of stable solutions containing same
12/21/1983EP0096463A1 Immunoglobulin half-molecules and process for producing hybrid antibodies
12/20/1983US4421902 Waterbase paints, drilling fluids
12/20/1983US4421747 Phospholipid and derivative of phenylacetic or phenylpropionic acid
12/20/1983US4421740 Hair conditioning composition and process for producing the same
12/13/1983CA1158557A1 Hydrolytic enzyme-activatible pro-drugs
12/13/1983CA1158553A1 Controlled release formulations and method of treatment
12/13/1983CA1158552A1 Controlled release parasitic formulations and method
12/08/1983WO1983004313A1 Human-human hybridomas for neoplasms
12/07/1983EP0095897A2 Pharmaceutical formulations
12/07/1983EP0095813A2 Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
12/07/1983EP0095751A1 Secretin composition and method for preventing the adsorption of secretin
12/07/1983EP0095591A1 Phospholipid solutions
12/06/1983CA1158161A1 Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent
12/06/1983CA1158159A1 Hydroxyalkyl starch drug carrier
12/06/1983CA1158158A1 Sulphonamide-potentiator combinations
11/1983
11/30/1983EP0095169A2 Improved penetration enhancers for transdermal drug delivery of systemic agents
11/29/1983US4418058 Protection of lyophilized betalactams from color formation
11/29/1983CA1157776A1 Directly compressible acetaminophen granulation
11/24/1983WO1983004026A1 Cytotoxic agent
11/24/1983WO1983003950A1 Mixture containing water and at least one active substance
11/23/1983EP0094844A2 Drug-carrier conjugates
11/23/1983EP0094513A2 Sustained-release body containing an active ingredient
11/22/1983CA1157377A1 Pharmaceutical preparations for rectal administration, and the production and suppository base thereof
11/16/1983EP0094157A1 Pharmaceutical composition and its use
11/16/1983EP0093999A2 Pharmaceutical formulations of oxicam derivatives, and process for preparing them
11/15/1983US4415665 Method of covalently binding biologically active organic substances to polymeric substances
11/15/1983US4415563 Topical application of medicine; cosmetics
11/15/1983US4415556 Antiischemic agents containing alpha-ketoglutaric acid; surgery; transplants
11/10/1983WO1983003757A1 Dry powder formulations having improved flow and compressibility characteristics, and method for the preparation thereof
11/09/1983EP0093563A2 Pharmaceutical preparation for endermic use
11/09/1983EP0093551A2 Pharmaceutical composition
11/09/1983EP0093341A2 Wool-wax substitute
11/08/1983US4414148 Anti-cancer drugs for the treatment of melanomas and method for preparing thereof
11/08/1983US4414147 Methods of decreasing the hydrophobicity of fibroblast and other interferons
11/08/1983CA1156558A1 Stable benzoyl peroxide composition
11/08/1983CA1156553A1 Process for the production of vaccine
11/08/1983CA1156509A1 Preparation of products for human or animal consumption using a sucrose substitute
11/02/1983EP0092918A2 Continuous release formulations